Paul Sondel
0000-0002-0981-8875
11 papers found
Refreshing results…
Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonist
Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial
Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination
GPC2 antibody–drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies
Local TLR4 stimulation augments in situ vaccination induced via local radiation and anti-CTLA-4 checkpoint blockade through induction of CD8 T-cell independent Th1 polarization
Mechanism of effective combination radio-immunotherapy against 9464D-GD2, an immunologically cold murine neuroblastoma
Mac Cheever (1944–2021): a tribute to a life of achievement and service
Combination of radiation therapy, bempegaldesleukin, and checkpoint blockade eradicates advanced solid tumors and metastases in mice
Depth of tumor implantation affects response to in situ vaccination in a syngeneic murine melanoma model
Intratumoral injection reduces toxicity and antibody-mediated neutralization of immunocytokine in a mouse melanoma model
Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
Missing publications? Search for publications with a matching author name.